Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 USD | +2.17% | -3.03% | -25.12% |
Apr. 17 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
Apr. 15 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.12% | 719M | |
-21.93% | 25.92B | |
-1.44% | 9.04B | |
-7.68% | 4.57B | |
-13.52% | 431M | |
+4.58% | 426M | |
-7.71% | 288M | |
-32.27% | 192M | |
-47.69% | 173M | |
-9.19% | 137M |
- Stock Market
- Equities
- WKME Stock
- News WalkMe Ltd.
- WalkMe Narrows Q4 Net Loss as Revenue Rises 37% Year-Over-Year; Also Sees Q1, FY22 Revenue Topping Street Views; Shares Plunge